Resmed Inc
ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory d…
The business
ResMed Inc. is a holding company. The Company, through its subsidiaries, in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. Its segments include Sleep and Breathing Health segment and the Residential Care Software segment. It also operates a Software as a Service (SaaS) business in the United States and Germany that includes out-of-hospital software platforms designed to support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. Its products and solutions are designed to improve patients' quality of life and reduce the impact of chronic disease. Its cloud-based digital health software applications, along with its devices, are designed to provide connected care.
Small Caps Research
No research on Resmed Inc yet
We cover the ASX small-cap market one company at a time. Request coverage and we’ll prioritise RMD based on demand.
Share price
Market Statistics
Valuation
Trading Activity
Latest news
Weekly wrap: market records and a 3.5% week show Australia enjoying its time in the sun
ASX closes down slightly after a 3.5% weekly rally to new highs, as AI jitters and Iran tensions keep investors wary.
Gold surge helps ASX to a weekly rise
Gold rally fuels ASX weekly gain as miners surge; Catalyst Metals +19%, Genesis Minerals +16%, Newmont +5%, Fortescue slips on China move.
Weekly Wrap: Market steps back from the brink with a rise
Weekly Wrap: Late pullback slams gold shares
ASX slips 0.7% as late pullback drags gold shares lower on Fed chair speculation; bullion drops ~5% amid rate-hike fears.
Looking for charts & signals? See the tab.
Unlock the full research library - free.
Create a free account to access every broker report, CEO interview, IPO alert, and daily market wrap. No credit card. No paywall.